Skip to content

Research on Prevention, Early Detection, and Clinical Evaluation of Intracranial Hemorrhage in Preterm Infants

A Multi-center and Multidisciplinary Research Project on Prevention, Early Detection, and Clinical Evaluation of Intracranial Hemorrhage in Preterm Infants

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07157020
Acronym
ROPEDACEOIHIPI
Enrollment
300
Registered
2025-09-05
Start date
2025-09-01
Completion date
2026-12-31
Last updated
2025-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraventricular Hemorrhage of Prematurity

Keywords

Intraventricular Hemorrhage of Prematurity, prevention, early detection, clinical evaluation

Brief summary

1. Establish a reference curve for the lateral ventricular diameter of premature infants and determine the intervention threshold for hydrocephalus after hemorrhage in premature infants based on the reference curve, providing a scientific basis for optimizing clinical intervention. 2. Apply ultrasound radiomics technology to explore and formulate new standards for imaging diagnosis and treatment; By integrating metabolomics, ultrasound radiomics and clinical data, high-risk individuals for intracranial hemorrhage and their relationship with prognosis can be identified early. 3. To explore whether advancing the indication for surgical intervention of hydrocephalus in preterm infants after hemorrhage from ventricular index P97+4mm to P97 and whether repeated lumbar puncture and drainage can improve their prognosis, with the aim of clarifying the optimal timing for intervention of hydrocephalus in preterm infants after hemorrhage and optimizing the treatment methods.

Interventions

PROCEDUREommaya capsule implantation technique

Intervention criteria: Low-threshold intervention group and high--threshold intervention group

Sponsors

Second Affiliated Hospital of Wenzhou Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
No minimum to 28 Days
Healthy volunteers
Yes

Inclusion criteria

* Gestational age: 23+0 weeks to 36+6 weeks; * Post-hemorrhagic hydrocephalus is confirmed by cranial ultrasound or other cranial imaging examinations. * No cerebrospinal fluid drainage treatment was received before enrollment.

Exclusion criteria

* Excluding secondary IVH, including but not limited to congenital malformations, vitamin K1 deficiency, abnormal coagulation function, etc. * Excluding hydrocephalus caused by other reasons, including but not limited to infection, congenital malformations, intracranial space-occupying lesions, etc. * Treatment before diagnosis of hydrocephalus after intraventricular hemorrhage or suspected presence of central nervous system infection.

Design outcomes

Primary

MeasureTime frameDescription
Death or the occurrence of neurodevelopmental disorders (NDI) before the corrected gestational age of 2 years.The assessment times are CA at 3 months, 6 months, 9 months, 12 months, 18 months, and 24 months respectively.NDI can be diagnosed if any of the following conditions are met. * Cerebral palsy; * Griffiths score \<85 points for the corresponding age: The assessment times are CA at 3 months, 6 months, 9 months, 12 months, 18 months, and 24 months respectively. Any assessment score lower than 85 points is considered a positive event. * Sensorineural or mixed hearing impairment and non-congenital hearing loss require hearing AIDS or cochlear implants ④ Bilateral visual impairment; * Epilepsy.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026